MEDICINOVA, INC. (MNOV) Free cash flow 2016–2025
MEDICINOVA, INC. (MNOV) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$9.8MFY2025 · since FY2016: -$6.6M → -$9.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.8M | +7.8% |
| FY2024 | -$10.6M | -42.8% |
| FY2023 | -$7.5M | +42.3% |
| FY2022 | -$12.9M | -37.3% |
| FY2021 | -$9.4M | +13.4% |
| FY2020 | -$10.9M | -18.9% |
| FY2019 | -$9.1M | -0.1% |
| FY2018 | -$9.1M | — |
| FY2016 | -$6.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More MNOV financial trends
MNOV RevenueMNOV Net incomeMNOV Net marginMNOV Gross profitMNOV Gross marginMNOV Operating incomeMNOV Operating marginMNOV Operating cash flowMNOV Capital expendituresMNOV Return on equityMNOV Stock buybacksMNOV Dividends paidMNOV Total assetsMNOV Total liabilitiesMNOV Shareholders’ equityMNOV overview →